Is slrx a buy hold or sell

**Salarius Pharmaceuticals (SLRX) is a speculative entity with significant volatility, and the decision to buy, hold, or sell should be based on a comprehensive analysis of the company's fundamentals and market dynamics.** Here's a detailed analysis to help you make an informed decision:

1. **Recent Price Movement**: SLRX has experienced a substantial price increase, with a 63.55% rise to $3.50 on July 25, 2024. This significant upswing could be due to speculative trading or positive market sentiment regarding the company's potential.

2. **Fundamental Analysis**:
- **Financial Health**: The company has a negative EPS (TTM) of -$21.7181 and a P/E (TTM) ratio of -0.14, indicating it is not currently profitable. This could be a red flag for investors.
- **Market Position**: Salarius focuses on developing treatments for cancers with high unmet medical need, which could be a promising area if the company is successful in its research.
- **Strategic Alternatives**: The company is exploring potential strategic alternatives, which could be positive if it leads to a beneficial partnership or acquisition.

3. **Technical Analysis**:
- **Moving Averages**: The 5-day moving average is $2.32, and the 10-day moving average is $2.09, suggesting a short-term upward trend. However, the stock is trading near its resistance level of $4.39, which could indicate a potential pullback.
- **Support and Resistance Levels**: The support level is at $2.28, which could be a critical point to watch if the stock price starts to decline.
- **RSI and MACD**: The RSI is at 50.81, indicating the stock is neither overbought nor oversold. The MACD is at 0.3, which could suggest a neutral trend.
- **KDJ**: The KDJ is at 12.34, which is relatively low and could indicate an oversold condition, potentially suggesting a reversal if the trend is bullish.

|Ticker|Name|5-Day Moving Average|10-Day Moving Average|Date|code|market_code|
|---|---|---|---|---|---|---|
|SLRX.O|Salarius|2.3240|2.0895|20240725|SLRX|185|

|Ticker|Name|RSI|MACD|KDJ|Date|code|market_code|
|---|---|---|---|---|---|---|---|
|SLRX.O|Salarius|50.8132||12.3437|20240724|SLRX|185|
|SLRX.O|Salarius||0.3001||20240725|SLRX|185|

4. **Market Sentiment**:
- **Short Interest**: The short interest in SLRX is not provided, but a high short interest can sometimes indicate bearish sentiment among investors.
- **Recent News**: Positive news about the company's ATM offering and potential financial lifelines could be driving the stock price up.

|Ticker|Name|Consensus Rating|Average Price Target|Date|code|market_code|
|---|---|---|---|---|---|---|
|SLRX.O|Salarius|||20240724|SLRX|185|

5. **Valuation Metrics**: The P/B ratio is at 0.58, which could suggest the stock is undervalued compared to the industry average. However, the P/S ratio is -0.14, which is negative and could indicate the company is not generating revenue efficiently.
6. **Expert Analysis**: There is no consensus rating or average price target available, which could mean that analysts are not covering the stock or have not provided specific recommendations.

In conclusion, while SLRX has shown significant potential based on recent price movements, the company's financial health and market sentiment suggest caution. Investors should consider their risk tolerance and investment strategy before making a decision. It may be prudent to conduct further research or consult with a financial advisor before investing in SLRX.